Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential-Reference-Cited by-同舟云学术

Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential

Published:2023-12 Issue: Volume:83 Page:102245
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Aurivillius Magnus^ORCID,Bednarczyk Artur,Kokot Marek,Madriaga Jonathan,Mei Jie,Collison Kathryn,Surujbally Raulin,Archbell James,Joshi Vidya,Gillen Michael

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference22 articles.

1. The evolution of pressurized metered-dose inhalers from early to modern devices;Roche;J. Aerosol Med. Pulm. Drug Deliv.,2016

2. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence;Aggarwal;Expet Rev. Respir. Med.,2014

3. The environmental impact of inhaled therapy: making informed treatment choices;Woodcock;Eur. Respir. J.,2022

4. Report of the UNEP Medical Technical Options Committee, 2015,2014

5. Delivering a 'Net Zero;Nhs England,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthma;Expert Opinion on Pharmacotherapy;2024-07-23

2. Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant;Pulmonary Pharmacology & Therapeutics;2024-06